Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127026401 | 12702640 | 1 | I | 20100816 | 20110519 | 20160831 | 20160831 | EXP | US-PFIZER INC-2011107175 | PFIZER | 72.00 | YR | F | Y | 76.64000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127026401 | 12702640 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK | Y | 18989 | TABLET | ||||||||
| 127026401 | 12702640 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
| 127026401 | 12702640 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 OR 40 MG, DAILY | 0 | ||||||||||
| 127026401 | 12702640 | 4 | C | DONNATAL | ATROPINE SULFATEHYOSCYAMINE SULFATEPHENOBARBITALSCOPOLAMINE HYDROBROMIDE | 1 | Oral | 2 TABS, 2X/DAY | 0 | 2 | DF | BID | |||||||
| 127026401 | 12702640 | 5 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 127026401 | 12702640 | 6 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, AS NEEDED | 0 | 50 | MG | ||||||||
| 127026401 | 12702640 | 7 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.625 MG, 1X/DAY | 0 | .625 | MG | QD | |||||||
| 127026401 | 12702640 | 8 | C | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 160 MG, 1X/DAY | 0 | 160 | MG | QD | |||||||
| 127026401 | 12702640 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0.1 MG, 1X/DAY | 0 | .1 | MG | QD | |||||||
| 127026401 | 12702640 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127026401 | 12702640 | 1 | Osteoarthritis |
| 127026401 | 12702640 | 2 | Rheumatoid arthritis |
| 127026401 | 12702640 | 3 | Prophylaxis |
| 127026401 | 12702640 | 4 | Irritable bowel syndrome |
| 127026401 | 12702640 | 5 | Urinary incontinence |
| 127026401 | 12702640 | 6 | Headache |
| 127026401 | 12702640 | 7 | Hormone replacement therapy |
| 127026401 | 12702640 | 8 | Hypertension |
| 127026401 | 12702640 | 9 | Hypothyroidism |
| 127026401 | 12702640 | 10 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127026401 | 12702640 | HO |
| 127026401 | 12702640 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127026401 | 12702640 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127026401 | 12702640 | 1 | 20080119 | 20101018 | 0 | |
| 127026401 | 12702640 | 4 | 20091215 | 0 | ||
| 127026401 | 12702640 | 5 | 20100802 | 0 | ||
| 127026401 | 12702640 | 6 | 20090811 | 0 | ||
| 127026401 | 12702640 | 7 | 20090811 | 0 | ||
| 127026401 | 12702640 | 8 | 20020510 | 0 | ||
| 127026401 | 12702640 | 9 | 20090131 | 0 | ||
| 127026401 | 12702640 | 10 | 20100106 | 0 |